ARCHIVES

In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

ASCO Recommends Beginning Palliative Care Alongside Standard Therapy in Metastatic NSCLC

February 24, 2012

NCI Study Says 2 Million US Women Could Benefit from Tamoxifen

April 11, 2003

ACCC Recommends Cancer Act Changes

August 27, 1976

House Preserves Funds For Space Station; Cancer Societies Reiterate Support For $170 Million Increase For NCI

August 7, 1992

In Brief: President Proposes $1,994 Billion For NCI;

February 10, 1995

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001